Association of transforming growth factor β1 (TGF-β1) with gingival hyperplasia in heart transplant patients undergoing cyclosporine-A treatment

Annals of Transplantation

Volumn 17, Issue 2, 2012, Pages 45-52

  Pakosz, Katarzyna ^a   Zakliczyński, Michał ^a   Król, Wojciech ^a   Pyka, Łukasz ^a   Zakliczyńska, Helena ^a   Trybunia, Dominika ^a   Wiench, Rafal ^a   Ilewicz, Leszek ^a   Skrzep Poloczek, Bronisława ^a   Przybylski, Roman ^a   Zembala, Marian ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cyclosporine A; Gingival hyperplasia; Heart transplantation; Interleukin 2; Transforming growth factor beta 1

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG BLOOD LEVEL; GINGIVA; GINGIVA HYPERPLASIA; HEART TRANSPLANTATION; HUMAN; STATISTICAL SIGNIFICANCE;

EID: 84863558319     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/aot.883222     Document Type: Article

References (37)

1. Stehlik J, Edwards LB, Kucheryavaya AY et al: The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. J Heart Lung Transplant, 2010; 29(10): 1089-103.
2. Delgado JF, Sánchez V, de la Calzada CS: Acute rejection after heart transplantation. Expert Opin Pharmacother, 2006; 7(9): 1139-49.
3. Hunt SA, Haddad F: The changing face of heart transplantation. J Am Coll Cardiol, 2008; 52(8): 587-98.
4. Dandel M, Lehmkuhl HB, Knosalla C, Hetzer R: Impact of different long-term maintenance immunosuppressive therapy strategies on patients' outcome after heart transplantation. Transpl Immunol, 2010; 23(3): 93-103.
5. Costanzo MR, Dipchand A, Starling R et al: International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant, 2010; 29(8): 914-56.
6. Dominiak A, Interewicz B, Swoboda E, Olszewski WL: Endogeneous sources of infection in transplant recipients. Ann Transplant, 2006; 11(4): 30-37.
7. Samonis G, Mantadakis E, Maraki S: Orofacial viral infections in the immunocompromised host. Oncol Rep, 2000; 7(6): 1389-94.
8. Ammatuna P, Campisi G, Giovannelli L et al: Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis, 2001; 7(1): 34-40.
9. Varga E, Tyldesley WR: Carcinoma arising in cyclosporin-induced gingival hyperplasia. Br Dent J, 1991; 171: 26-33.
10. Daley TD, Wysocki GP, Day C: Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol, 1986; 62: 417-21.
11. Rataeischak-Plüss EM, Hehti A, Lortscher R, Thiel G: Initial observation that cyclosporin- A induces gingival enlargement in man. J Clin Peridontol, 1983; 10: 237-46.
12. Montebugnoli L, Bernardi F, Magelli C: Cyclosporin-A-induced gingival overgrowth in heart transplant patients. A cross-sectional study. J Clin Periodontol, 1996; 23: 868-72.
13. Thomason JM, Seymour RA, Ellis JS et al: Determinants of gingival overgrowth severity in organ transplant patients. An examination of the role of HLA phenotype. J Clin Periodontol, 1996; 23(7): 628-34.
14. Morisaki I, Fukui N, Fujimori Y et al: Effects of combined oral treatments with cyclosporine A and nifedipine or diltiazem on drug-induced gingival overgrowth in rats. J Periodontol, 2000; 71: 438-43.
15. Seymour RA, Thomason JM, Ellis JS: The patogenesis of drug-induced gingival overgrowth. J Clin Periodontol, 1996; 23: 165-75.
16. Mariani G, Calastrini C, Carinci F et al: Ultrastructural features of cyclosporine A-induced gingival hyperplasia. J Periodontol, 1993; 64: 1092-97.
17. Thomason JM, Seymour RA, Ellis JS et al: Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol, 1995; 66: 742-46.
18. Kozak M, Kurzawski M, Wajda A et al: TGF-b1 gene polymorphism in renal transplant patients with and without gingival overgrowth. Oral Dis, 2011; 17(4): 414-19.
19. Ghafari A, Poorabbas R, Takieh JA et al: Gingival enlargement and its risk factors in kidney transplant patients receiving cyclosporine A. Iran J Kidney Dis, 2010; 4(1): 66-70.
20. Pernu HE, Pernu LM, Knuuttila ML: Effect of periodontal treatment on gingival overgrowth among cyclosporine A-treated renal transplant recipients. J Periodontol, 1993; 64: 1098-100.
21. Montebugnoli L, Montanari G: Vasovagal syncope in heart transplant patients during dental surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1999; 87: 666-82.
22. Thomason JM, Kelly PJ, Seymour RA: The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol, 1996; 23: 367-76.
23. Margiotta V, Pizzo I, Pizzo G, Barbaro A: Cyclosporin and nifedipine induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters and HLA-antigens. J Oral Pathol Med, 1996; 25: 128-35.
24. Pernu HE, Pernu LM, Huttunen KR: Gingival overgrowth among renal transplant recipients related to immunosupressive medication and possible local background factors. J Periodontol, 1992; 63: 548-57.
25. Nabel GJ: A transformed view of cyclosporine. Nature, 1999; 397: 471-72.
26. Bartold PM: Cyclosporine-induced gingival overgrowth. J Oral Pathol, 1988; 16: 463-68.
27. James JA, Irwin CR, Linden J: The effects of culture environment on the response of human gingival fibroblasts to cyclosporine A. J Periodontol, 1995; 66: 339-44.
28. Myrillas TT, Linden GJ, Marley JJ, Irwin CR: Cyclosporin A regulates interleukin-1b and interleukin-6 expression in gingiva: implications for gingival overgrowth. J Periodontol, 1999; 70: 294-300.
29. Saito K, Mori S, Iwakura M, Sakamoto S: Immunohistochemical localization of transforming growth factor b basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedypine and phenytoin. J Periodontal Res, 1996; 31: 545-55.
30. Narayanan AS, Page RC, Swanson J: Collagen synthesis by fibroblasts. Regulation by transforming growth factor-b in the presence of other inflamatory mediators. Biochem J, 1989; 260: 463-69.
31. Tipton DA, Dabbous MK: Autocrine transforming growth factor b of extracellular matrix production by fibroblasts from fibrotic human gingiva. J Periodontol, 1998; 69: 609-19.
32. Khanna AK: Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. Transplantation, 2000; 70: 690-94.
33. James JA, Irwin CR, Linden GJ: Gingival fibroblast response to cyclosporin A and transforming growth factor b1. J Periodontal Res, 1998; 33: 40-48.
34. Thomason JM, Seymour RA, Rice N: The prevalence and severity of cyclosporin and nifedypine- induced gingival overgrowth. J Clin Periodontol, 1993; 20: 37-40.
35. Chae HJ, Ha MS, Yun DH et al: Mechanism of cyclosporine-induced overgrowth in gingiva. J Dent Res, 2006; 85(6): 515-19.
36. Stefanidou V, Liakopoulos V, Eleftheriadis T et al: Expression of transforming growth factor-beta receptor II mRNA in cyclosporine-induced gingival overgrowth. Transplant Proc, 2006; 38(9): 2905-8.
37. Radwan-Oczko M, Boratyńska M, Zietek M, Do-bosz T: Transforming growth factor-beta1 gene expression and cyclosporine A-induced gingival overgrowth: a pilot study. J Clin Periodontol, 2008; 35(5): 371-78